Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
2.210
+0.100 (4.74%)
At close: Mar 31, 2026, 4:00 PM EDT
2.190
-0.020 (-0.90%)
After-hours: Mar 31, 2026, 4:00 PM EDT

Aethlon Medical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2021FY 2020
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
36492325
Market Cap Growth
-35.78%30.17%-49.44%-61.19%-8.73%73.25%
Enterprise Value
-3.170.59-0.37-4.865.914.67
Last Close Price
2.2128.60134.40304.001168.001624.00
PE Ratio
--0.33-0.35-0.65-0.21-0.31
PS Ratio
---15.2176.5237.42
PB Ratio
0.311.120.770.581.312.62
P/TBV Ratio
0.130.870.730.520.130.26
P/FCF Ratio
--0.75-0.43-0.76-2.23-3.61
P/OCF Ratio
--0.75-0.44-0.83-2.30-3.65
EV/Sales Ratio
----8.4620.0522.25
EV/EBITDA Ratio
--0.070.030.42-0.57-1.87
EV/EBIT Ratio
--0.060.030.41-0.57-1.86
EV/FCF Ratio
--0.080.040.42-0.58-2.15
Debt / Equity Ratio
0.010.070.110.060.040
Debt / EBITDA Ratio
-0.06-0.07-0.08-0.10-0.070.00
Debt / FCF Ratio
-0.06-0.08-0.09-0.11-0.07-0.01
Net Debt / Equity Ratio
-0.97-0.95-0.78-0.88-0.95-1.04
Net Debt / EBITDA Ratio
0.930.540.371.141.591.25
Net Debt / FCF Ratio
0.950.640.431.161.621.44
Asset Turnover
-000.030.020.06
Quick Ratio
5.532.902.979.669.437.28
Current Ratio
5.683.133.4010.039.957.53
Return on Equity (ROE)
-131.64%-245.88%-117.21%-75.87%-79.29%-84.99%
Return on Assets (ROA)
-101.06%-119.72%-98.13%-64.44%-69.27%-74.96%
Return on Invested Capital (ROIC)
-2350.11%-840.09%-663.58%-592.16%-1021.17%-2140.63%
Return on Capital Employed (ROCE)
-127.57%-157.31%-112.73%-70.83%-77.51%-84.79%
Earnings Yield
-341.54%-300.00%-289.21%-154.21%-486.30%-320.20%
FCF Yield
-205.13%-132.95%-234.97%-131.03%-44.94%-27.67%
Buyback Yield / Dilution
-240.14%-396.93%-22.35%-1291.71%-22.05%-254.07%
Total Shareholder Return
-240.14%-396.93%-22.35%-1291.71%-22.05%-254.07%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q